Fig. 12 | Scientific Reports

Fig. 12

From: ​Identification of a novel m6A RNA methylation regulator-based signature for prognosis and immune landscape prediction in hepatocellular carcinoma

Fig. 12

​Correlation of m6A-RPS with chemotherapy and immunotherapy efficacy. (A) Assessment of response to common chemotherapy drugs in patients with low- and high-m6A-RPS scores. (B) The heat map of the 10 immune checkpoints correlated to m6A-RPS. (C, D) TCIA and TIDE scores discrepancy between low- and high-risk groups. ns P ≥ 0.05; * P < 0.05; ** P < 0.01 and *** P < 0.001

Back to article page